Placebo and Active Controlled Study to Assess Efficacy and Tolerability of Aspirin Plus Pseudoephedrine
Completed · Phase 3 · Has a placebo group
Conditions studied: Common Cold, Pharyngitis
In brief
The purpose of this study is compare efficacy and tolerability of a fixed combination, containing 500 mg Acetylsalicylic acid and 30 mg Pseudoephedrine, in comparison to its single components in patients with sore throat and nasal congestion.
Key facts
- Study ID
- NCT01062360
- Run by
- Bayer
- People needed
- 1016
- Starts
- 2005-12-23
- Expected to finish
- 2007-05-14
- Last updated by the study team
- 2017-09-01
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Study site — New York, New York, United States
- Study site — Alassio, Italy
- Study site — Albenga, Italy
- Study site — Arenzano, Italy
- Study site — Civitella Marittima, Italy
- Study site — Follonica, Italy
- Study site — Genova, Italy
- Study site — Genova, Italy
- Study site — Genova, Italy
- Study site — Genova, Italy
- Study site — Genova, Italy
- Study site — Genova, Italy
- Study site — Genova, Italy
- Study site — Genova, Italy
- Study site — Genova, Italy
- Study site — Genova, Italy
- Study site — Grosseto, Italy
- Study site — Grossetto, Italy
- Study site — Isola del Cantone, Italy
- Study site — Loano, Italy
- Study site — Masone, Italy
- Study site — Orbetello, Italy
- Study site — Pegli, Italy
- Study site — Quiliano, Italy
- Study site — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.